tradingkey.logo

BRIEF-Scholar Rock Holding To Submit MAA To EMA In 1Q 2025

ReutersJan 29, 2025 1:07 PM

- Scholar Rock Holding Corp SRRK.O:

  • SCHOLAR ROCK SUBMITS BIOLOGICS LICENSE APPLICATION (BLA) TO THE U.S. FDA FOR APITEGROMAB AS A TREATMENT FOR PATIENTS WITH SPINAL MUSCULAR ATROPHY (SMA)

  • SCHOLAR ROCK HOLDING CORP - TO SUBMIT MAA TO EMA IN 1Q 2025

  • SCHOLAR ROCK HOLDING CORP - REQUESTS PRIORITY REVIEW FOR APITEGROMAB

Source text: ID:nBw80d9q0a

Further company coverage: SRRK.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI